News about Research
The HCB-IDIBAPS Biobank has obtained ISO 20387 accreditation, the leading international standard of excellence and quality
The HCB-IDIBAPS Biobank has obtained ISO 20387 accreditation, an international standard specifically designed for biobanks that certifies technical...
Predictions of a patient’s symptom progression can seem more accurate than they really are
In medicine, tools are increasingly being use to predict a patient’s symptom progression, identify individuals at risk, or to estimate the response...
World Cancer Research Day: research to transform the future of patients
On World Cancer Research Day, 24 September, we would like to highlight some of the most significant advances made over the past year by Clínic-IDIB...
A new system enables the early detection of drug-induced liver toxicities in primary care
A study led by professionals from the Clínic-IDIBAPS and the Barcelona Esquerra Primary Healthcare Consortium (CAPSBE) has developed a system for t...
A study by the Clínic-IDIBAPS delves into the genetic basis of psychotic disorders in children and adolescents
A study led by the Clínic-IDIBAPS provides new clues about the genetic basis of psychotic disorders such as schizophrenia and bipolar disorder. Th...
Clínic-IDIBAPS professionals create an open-access platform on treatments for bipolar disorder
The Clínic-IDIBAPS has led the development of EBI-BD, a new open-access, interactive web platform that synthesizes all the available scientific evi...
Thomas Walle receives an ERC Starting Grant to study how the immune system slows down the development of tumours
Thomas Walle, head of the IDIBAPS Computational cancer biomedicine group has received a Starting Grant from the European Research Council (ERC) in...
A study by the Clínic-IDIBAPS provides new insights into the genetics of IRF4-rearranged lymphomas in adults and young people
A study led by the IDIBAPS Molecular genetics of paediatric lymphomas research group has identified genetic, biological and clinical differences b...
A new dual-target CAR-T therapy improves follicular lymphoma control in preclinical models
A study led by researchers from the Hospital Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Centre, has identified CD70 as a mark...